Mylab INC

Mylab INC was paid $857K by Medicaid between Feb 2020 and May 2023, across 21 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 73% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Michigan

Rank by total paid#47 of 108

Median peer was paid$588K

This provider vs. median1.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	30	$179.64
2021	14,334	$494K
2022	9,180	$363K
2023	25	$0.00

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	73%	10,412	9,617	$624K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	23%	10,523	9,722	$201K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	2.9%	397	383	$25K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	146	142	$2K
86328		<1%	28	28	$1K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	176	176	$514.71
80061	Lipid panel	<1%	255	254	$492.33
84443	Thyroid stimulating hormone (TSH)	<1%	150	149	$467.43
82607		<1%	188	179	$405.66
80053	Comprehensive metabolic panel	<1%	239	239	$390.72
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	213	210	$329.20
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	41	41	$325.39

9 more codes

87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	42	$325.39
83036	Hemoglobin; glycosylated (A1C)	<1%	150	$258.92
84439		<1%	146	$245.78
82043		<1%	34	$45.43
82570		<1%	33	$40.74
87086	Culture, bacterial; quantitative colony count, urine	<1%	18	$6.68
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	0%	96	$0.00
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	0%	257	$0.00
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	0%	25	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHABIB, SYED (PRESIDENT)